of such calendar year, during the portion of time in such calendar year that the drug was marketed. (2) Timeline for initial submission (A) Drugs marketed before December 31, 2020 Each manufacturer of a prescription drug that is marketed at any time during calendar year 2020, shall submit to the Secretary, not later than April 1, 2021— (i) the information required under paragraph (1)